Results 111 to 120 of about 52,862 (295)
Clinical Oral Implants Research, EarlyView.ABSTRACT Objectives Medication‐related osteonecrosis of the jaw (MRONJ) is a debilitating condition associated with antiresorptive agents (ARAs) and can occur around well‐osseointegrated dental implants. Although implant presence–triggered osteonecrosis (IPTO) has been primarily linked to bacteria‐related peri‐implantitis, whether occlusal trauma ...
Eun‐Bin Bae +11 more
wiley +1 more source
Effect of bisphosphonate use on orthodontic tooth movement: A Systematic Review
Brazilian Dental ScienceStatement of problem: As bisphosphonates have an action mode which interferes in the osteo-resorptive process, their use during dental treatment may occasionally have side effects, such as: inhibition of tooth movement, delayed bone healing, and ...
Gurgiane Rodrigues Gurgel Lessa +4 more
doaj +1 more source
In vitro assay of the biological activity of bisphosphonates [PDF]
, 2015 Nowadays, the use of bisphosphonates are the gold standard of treatment of bone diseases. Due to the high utility of these compounds, scientists still search for better and better structures, with a variety of substituents at carbon’s atom and create new
Chmielewska, E. +4 more
core
Musculoskeletal health among adults with cerebral palsy: A systematic review
Developmental Medicine &Child Neurology, EarlyView.Abstract Aim To describe the burden of, and investigate prognostic factors for, osteoarthritis, osteopenia and/or osteoporosis, spondylosis, and fracture, and to investigate the effectiveness of protocols for monitoring musculoskeletal disorders and interventions for managing osteoarthritis in adults with cerebral palsy (CP).
Jennifer M. Ryan +11 more
wiley +1 more source
Bisphosphonates: from preclinical evidence to survival data in the oncologic setting
Oncology Reviews, 2011 Bisphosphonate therapy has become a standard of therapy for patients with malignant bone disease. In vivo pre-clinical data suggest that bisphosphonates may exert an antitumor effect and preliminary clinical data show promising activity on metastatic ...
Daniele Santini +6 more
doaj +2 more sources
, 2011 Allan LiptonMilton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA, USAAbstract: Bisphosphonates inhibit osteoclast-mediated bone resorption, thereby inhibiting the release of growth factors necessary to promote cancer cell growth ...
Allan Lipton
core
Dental Traumatology, EarlyView.ABSTRACT Invasive cervical resorption is a clinically challenging and often silent form of external root resorption that may remain undetected until substantial structural damage has occurred. Although traumatic dental injuries are repeatedly cited as potential predisposing factors, the strength, consistency, and clinical meaning of this association ...
Thiago Farias Rocha Lima +5 more
wiley +1 more source
European Journal of Haematology, EarlyView.ABSTRACT Background Higher von Willebrand factor (VWF) levels and lower ADAMTS13 activity are linked to increased risk of atherosclerotic cardiovascular disease, but their association with atherosclerosis burden, a potential underlying mechanism, remains unclear.
Mitra Nekouei Shahraki +4 more
wiley +1 more source
Extra-skeletal effects of bisphosphonates.
, 2007 Bisphosphonates are pharmacological agents which are currently used both in osteoporosis than in other pathological conditions characterised by an increased bone resorption, such as Paget’s disease of bone, malign hypocalcaemia during myeloma ...
CANTATORE, FRANCESCO PAOLO +2 more
core
Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor.
, 2013 Amino-bisphosphonates (N-BPs)haveawiderangeofclinicalapplicationstotreatbonediseases.Their Amino-bisphosphonates (N-BPs)haveawiderangeofclinicalapplicationstotreatbonediseases.Their activity loweredfarnesylpyrophosphate(FPP ...
Reno’, Filippo +5 more
core +1 more source